As members of the World Health Organizations (WHO) global Stop TB Partnership, Fiberlock knows the importance of protective countermeasures in the fight to rid the planet of Tuberculosis. With rising instances of MDR-TB world wide, infection control practices in healthcare facilities play a key role in stopping the spread of this dangerous and costly disease.

What is Drug Resistant TB?
A Drug Resistant strain of tuberculosis is a strain of the disease that is resistant to a single drug used in the treatment of TB. As drugs are incorrectly prescribed or patients do not complete treatment drug resistant strains of the disease develop. Some of these drug resistant strains develop into strains that are resistant to multiple drugs. Multiple drug resistant Turberculosis are defined by TB Bacilli resistant to at least isoniazid and rifampicin (the two most powerful anti-TB Drugs), and is difficult and costly to treat. A looming threat on the horizon is XDR-TB or extensively drug resistant tuberculosis now being found particularly in settings where patients are infected with HIV and TB.